FACTS AT A GLANCE
Edition: 17; Released: May 2021
Executive Pool: 1373
Companies: 78 – Players covered include Actinium Pharmaceuticals, Inc.; Alliance Medical; Alseres Pharmaceuticals, Inc.; Avid Radiopharmaceuticals; Avid Bioservices Inc; Bayer HealthCare Pharmaceuticals; Bracco Diagnostics, Inc.; Cardinal Health, Inc.; GE Healthcare; Ion Beam Applications S.A; Immunomedics, Inc.; Jubilant Pharma; Lantheus Medical Imaging Inc.; Medi-Radiopharma Ltd; Nordion, Inc.; Novartis/Advanced Accelerator Applications; PETNET Solutions Inc.; Positron Corporation and Others.
Coverage: All major geographies and key segments
Segments: Product Type (SPECT Radioisotopes, PET Radioisotopes, Beta Emitters, Alpha Emitters, Other Product Types); Application (Oncology, Cardiology, Neurology, Other Applications); End-Use (Hospitals & Diagnostic Centers, Ambulatory Surgical Centers, Other End-Uses)
Geographies: World; USA; Canada; Japan; China; Europe; France; Germany; Italy; UK; Spain; Russia; Rest of Europe; Asia-Pacific; Australia; India; South Korea; Rest of Asia-Pacific; Latin America; Argentina; Brazil; Mexico; Rest of Latin America; Middle East; Iran; Israel; Saudi Arabia; UAE; Rest of Middle East; Africa.
Complimentary Project Preview – This is an ongoing global program. Preview our research program before you make a purchase decision. We are offering a complimentary access to qualified executives driving strategy, business development, sales & marketing, and product management roles at…
